SUVEN PHARMACEUTICALS LTD.

NSE : SUVENPHARBSE : 543064ISIN CODE : INE03QK01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE671.201.7 (+0.25 %)
PREV CLOSE ( ) 669.50
OPEN PRICE ( ) 670.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1762
TODAY'S LOW / HIGH ( )658.50 674.55
52 WK LOW / HIGH ( )427.05 767
NSE672.102.5 (+0.37 %)
PREV CLOSE( ) 669.60
OPEN PRICE ( ) 670.00
BID PRICE (QTY) 672.10 (5)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 157209
TODAY'S LOW / HIGH( ) 657.00 674.90
52 WK LOW / HIGH ( )469.45 768
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax5597.306675.904676.744045.121578.67
Adjustment313.38406.34364.81346.03139.25
Changes In working Capital56.36-1939.66-121.73542.11-883.26
Cash Flow after changes in Working Capital5967.045142.584919.824933.26834.66
Cash Flow from Operating Activities4509.123300.003825.474069.17504.05
Cash Flow from Investing Activities-1948.42-1361.38-3113.98-4134.47-654.80
Cash Flow from Financing Activities-2358.31-1564.81-756.6273.22259.78
Net Cash Inflow / Outflow202.39373.81-45.137.92109.03
Opening Cash & Cash Equivalents445.6471.82116.95109.03NA
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNA0.000.000.01NA
Closing Cash & Cash Equivalent648.03445.6471.82116.95109.03

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.